“…It readily crosses the placenta and is concentrated in the fetal compartment (Luck, Nau, Hansen, & Steldinger, 1985) where it binds to nicotinic acetylcholine receptors that are widely expressed throughout the fetal nervous system, lungs, and other fetal tissues (Hellström-Lindahl, Gorbounova, Seiger, Mousavi, & Nordberg, 1998;Wongtrakool, Wang, Hyde, et al, 2012). Both human and animal pregnancy exposure studies show nicotine to be a developmental toxicant (Lin, Yon, Jung, et al, 2012;Ozturk et al, 2016;Schneider, Bizarro, Asherson, & Stolerman, 2010;Wickström, 2007) that is capable of interfering with normal neurotransmitter function, resulting in apoptosis and mitotic abnormalities (Slotkin, 2008;Wickström, 2007;Zhao & Reece, 2005), inducing lung (Maritz & Harding, 2011) and neurodevelopmental abnormalities (Dwyer, Broide, & Leslie, 2008;Slotkin, Seidler, Qiao, et al, 2004), and causing genotoxic effects in human fetal cells in vitro (Demirhan et al, 2011). A recent review of extant human and animal research concerning the developmental toxicity of nicotine concluded that "….nicotine contributes critically to adverse effects of gestational tobacco exposure" (England et al, 2017).…”